CA
NZ
UK
AU
IND
US
● Gross margin reached about 20.9%, against a gross loss a year earlier.
● Class A shares outstanding fall from about 105.7 million to about 1.32 million.
Humana Inc. (NYSE:HUM) stands as one of the United States’ premier managed healthcare organizations and health insurance providers, maintaining an influential constituent presence within the S&P 500 index. Headquartered in Louisville, Kentucky, Humana has distinguished itself by executing a focused, pure-play strategic commitment to …
Moderna, Inc. (NASDAQ:MRNA), a pioneer in messenger RNA (mRNA) therapeutics and biotechnology vaccines headquartered in Cambridge, Massachusetts, stands as an established biopharmaceutical constituent within major US market indices. Having achieved historic scientific and commercial success by delivering one of the world’s first approved COVID-19 …
● Skyrizi and Rinvoq together exceeded $8.0 billion, while Humira fell 35.9%.
● GAAP net earnings were $210 million, down 95.9%, after a one-time special charge.
● Realised prices fell 13%, partly offsetting the volume increase.
● A $5.7 billion charge relating to the Terns acquisition drove the accounting loss.
● Kisqali sales rose 43% in constant currencies to US$1.7bn.
● Aardvark terminated the Phase 3 HERO trial and open-label extension in June 2026.
Please wait processing your request...